Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CanBiosimilars
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CanBiosimilars
-
The .
@US_FDA and Federal Trade Commission announced a partnership to support biosimilars by targeting “anti-competitive business practices,” such as false or misleading promotions#biosimilarshttps://www.healio.com/rheumatology/practice-management/news/online/%7B2561d6d3-f1a4-494b-b17f-2cadad5cee66%7D/fda-federal-trade-commission-to-target-anti-competitive-practices-to-support-biosimilars?utm_medium=social&utm_source=twitter&utm_campaign=sociallinks …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
According to a report by
@ODPRN_Research, by 2021, Ontario's biologics expenditure will likely increase to $1.4 billion for an estimated 564,672 users. See the full report here https://odprn.ca/wp-content/uploads/2020/01/Utilization-of-Innovator-Biologics-and-Biosimilars-in-Ontario.pdf …#biosimilarsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
We respect the concerns of patients but the fear that biosimilars are not safe is 10 years out of date. The current evidence is clear: they're clinically equivalent, no added risk, based on experience w switching in BC and Norway, and 10 years of biosimilars in Europe overall.https://twitter.com/RachelNotley/status/1217530975737065472 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
CanadianBiosimilars proslijedio/la je Tweet
As more
#biosimilars are used in oncology treatment, providers have the opportunity to significantly reduce prescription drug costs for their patients by choosing#biosimilars says@OubreKathyhttps://www.ajmc.com/journals/evidence-based-oncology/2019/december-2019/empower-physicians-to-fight-financial-toxicity-with-biosimilars …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biosimilars have no safety or efficacy differences from other Health Canada-approved biologic medicines.
@GovCanHealth approves biosimilars only after they meet rigorous standards.#biosimilars#cdnhealthpic.twitter.com/bpOLEs0MTg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Should government have a say in what drugs are prescribed to patients? by
@picardonhealth https://www.theglobeandmail.com/opinion/article-should-government-have-a-say-in-what-drugs-are-prescribed-to-patients/?utm_medium=Referrer:+Social+Network+/+Media&utm_campaign=Shared+Web+Article+Links … via@GlobeDebate#biologics#biosimilars#Remicade#pharmacare#cdnhealthPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A quote from
@shandro on Alberta's biosimilars initiative. The province alone spent $238M on biologics in 2018-19, up from $21M a decade earlier.pic.twitter.com/ZKc6b415xn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Did you know? Our Biosimilars Initiative included consultations with:
physicians (from Alberta, BC and Europe)
nurse practitioners

@AlbertaRNs
@Albertadoctors
@ABPharmacists
@TheCDHF
patients groups
patients
infusion clinics
manufacturers
Five @AHS_SCN'sHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biosimilar medications can generate cost savings and increase access to care across Canada. British Columbia will save nearly $100M over the next three years, and Alberta is projected to save $227M to $380M over the next four years, to be reinvested back into the health systempic.twitter.com/WItZ20JFlD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
ATTN: Alberta Health has recently made policy changes that will affect certain IBD Patients on Remicade. To learn more about who is affected by this change and other pertinent information regarding patients currently on a biologic, please click this link: https://bit.ly/2RVmPr8 pic.twitter.com/w7MXYzS5yp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
The chart here shows the similarities between versions of biologics (red) and biosimilars (blue). There's natural variation anyway as using living cells means they can't be exactly the same every time. However that does not affect their effectiveness.pic.twitter.com/TuJHDNpiF3
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Correct. One-time, ad hoc, short-term deals with one manufacturer undermine the pan-Canadian Pharmaceutical Alliance and undermine the estimated $227-million to $380-million we estimate to save in three years with the biosimilars initiative. It doesn’t add up.https://twitter.com/Jantafrench/status/1205321955236143105 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Congratulations to
#Alberta on their new biosimilars initiative. It’s the right thing to do and shows the advantages of our ongoing work together on PharmaCare issues. We hope and expect to see more provinces join ushttps://news.gov.bc.ca/21231Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Alberta’s policy expanding the use of biosimilar prescription drugs will save hundreds of millions of dollars while providing the same safe, effective treatment: http://bit.ly/2RL42yM
#abhealthHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Health Canada has stated definitively there are no differences in safety or efficacy following a change in routine use between a biosimilar and a biologic drug.
#biosimilars#abhealth#ablegpic.twitter.com/M4Ir4NUt9U
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Alberta will be the third province to expand use of biosimilars, following BC and Manitoba in giving patients safe and effective therapy at lower cost. In Europe, biosimilars have been used since 2006 and have proven to be safe.
#biosimilars#abhealth#ablegpic.twitter.com/SKmAtgPaOU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Alberta to announce details of well controlled switch policy, expanding use of biosimilars and saving the government $227-million to $380-million over the next four years
@shandrohttps://www.theglobeandmail.com/canada/article-alberta-drug-plans-biosimilars-biologics-medications-arthritis-crohns/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CanadianBiosimilars proslijedio/la je Tweet
Big Pharma threatens patients over biosimilars | EYEVIEW by
@dcharbonneau13 : http://bit.ly/2XUgkWN pic.twitter.com/cNmNSZB84r
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking for simple, evidence based info on switching to a
#biosimilar for patients with IBD?@TheCDHF The Canadian Digestive Health Foundation just released a great video answering commonly asked questions.#IBDhttps://cdhf.ca/digestive-disorders/crohns-disease/ibd-switching-from-a-biologic-to-a-biosimilar/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.